Current Status of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease

作     者：De-Shun Liu Xiu-Di Han Xue-Dong Liu Liu De-Shun;Han Xiu-Di;Liu Xue-Dong

作者机构：Department of Respiratory Medicine Qingdao Municipal Hospital Qingdao Shandong 266011 China 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2018年第131卷第9期

页      面：1086-1091页

核心收录：

学科分类：03[法学] 07[理学] 08[工学] 070602[理学-大气物理学与大气环境] 0837[工学-安全科学与工程] 0838[工学-公安技术] 0706[理学-大气科学] 0306[法学-公安学] 

主　　题：Chronic Obstructive Pulmonary Disease Community-Acquired Pneumonia Morbidity Treatment 

摘      要：Objective：Worldwide,community-acquired pneumonia （CAP） is a common infection that occurs in older adults,who may have pulmonary comorbidities,including chronic obstructive pulmonary disease （COPD）.Although there have been clinical studies on the coexistence of CAP with COPD,there remain some controversial *** review presents the current status of COPD in CAP patients,including the disease burden,clinical characteristics,risk factors,microbial etiology,and antibiotic *** Sources：A literature review included full peer-reviewed publications up to January 2018 derived from the PubMed database,using the keywords ＂community-acquired pneumonia＂ and ＂chronic obstructive pulmonary disease＂.Study Selection：Papers in English were reviewed,with no restriction on study ***：COPD patients who are treated with inhaled corticosteroids are at an increased risk of CAP and have a worse prognosis,but data regarding the increased mortality remains *** Streptococcus pneumoniae is still regarded as the most common bacteria isolated from patients with CAP and COPD,Pseudomonas aeruginosa is also important,and physicians should pay close attention to the occurrence of antimicrobial resistance,particularly in these two ***：COPD is a common and important predisposing comorbidity in patients who develop *** often aggravates the clinical symptoms of patients with CAP,complicating treatment,but generally does not appear to affect prognosis.